Of the 67 patients included in the study, 42 had anti-LGI1 encephalitis, 13 anti-NMDA-R encephalitis, 8 anti-GABA-B-R encephalitis, and 4 anti-CASPR-2 encephalitis. This evidence concerns the gene CNTNAP1 and viral encephalitis.